Clinical Data
The Driver Stent has proven clinical efficacy both in registries and a randomized controlled trial.
Efficacy Demonstrated Both In Registries and a Randomized Controlled Trial
Confidence In Clinical Outcomes
- Nearly 600 patients followed to 5 years1
- More than 3400 patients studied2
1ENDEAVOR II, Driver control arm.
2More than 3400 patients studied includes:E II Driver arm (n=599), Driver registry (n=298), International Driver Registry (n=792), DRASTIC (n=805), DRASTIC II (n=600), Micro Driver registry (n = 135), CLASS study (n=202) .
Low TLR In Registries
Comprehensive Experience In Real-World Patients
CLASS study 6-mo TLR. Driver Registry 9-mo TLR; International Driver Registry 9-mo TLR.
Durable Efficacy to 5 Years In Pivotal Trial
- 16.3% at 5 years, an increase of just over three percent from 13.1% four years earlier
Years 1–5 TLR E II 5-year, Driver control arm.
| Baseline Characteristics ENDEAVOR II: Driver Control Arm |
n = 599 |
| Diameters (mm) | 2.25–3.5 |
| Primary endpoint | TVF at 9 mo |
| RVD (mm) | 2.76 |
| Lesion length (mm) | 14.38 |
| Pre-procedure MLD (mm) | 0.84 |
| Diabetes (%) | 22.2 |
| B2/C (%) | 79.0 |